News | July 28, 2021
Granules India Q1FY22 consolidated net profit at Rs. 120.20 Cr
The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.
The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.
The company has reported total income of Rs.45.29 crores during the 12 months period ended March 31, 2021
India is expecting to manufacture 30-35 crore COVID-19 vaccines between July - August 2021
Sun Pharma is granted rights for co-marketing of the drug in India in the private market under the brand name CARITEC
EPL will supply APR approved 100% recyclable and fully sustainable Platina Tubes for the toothpaste category of Unilever
Mucormycosis drug AmphoTLC will be imported from Taiwan by Stelis Biopharma Private Limited (Stelis), the biotech arm of Strides group, and will be launched and distributed in India immediately by Strides
With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage
The antibody cocktail is to be administered for the treatment of mild to moderate COVID-19
BALflu is approved by DCGI for emergency use for the treatment of COVID-19
The company has reported total income of Rs.826.40 crores for FY 2020-21
Subscribe To Our Newsletter & Stay Updated
